Position in FATE
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$110,014
+$20,170 QoQ
Shares Held
91,679
0.0% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 16.533775455665964.ToString("F0")%
Shared 0.ToString("F0")%
None 83.46622454433404.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. FATE ranks #226 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in FATE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $110,014 | 91,679 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $89,844 | 91,679 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $198,020 | 157,159 | Shares | Defined | 2025-11-13 | |
| 2024-09-30 | $194,820 | 55,663 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $109,725 | 33,453 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $293,467 | 39,982 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $141,465 | 37,825 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $94,803 | 44,719 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $1,168,246 | 245,430 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $344,895 | 60,508 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,357,810 | 233,678 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,997,518 | 223,004 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,421,844 | 138,089 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $5,770,292 | 148,834 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $8,920,550 | 152,462 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $47,926,312 | 808,610 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $68,742,972 | 792,061 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $14,104,059 | 171,062 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $5,285,941 | 58,132 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $5,796,407 | 145,019 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $11,653,080 | 339,641 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,595,032 | 71,816 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||